About Keith Flaherty
Form D filings for Strata Oncology from 2018 to 2024 list Keith Flaherty as director.
Keith Flaherty first appears on SEC filings in 2018.
Experience
This experience comes from SEC filings. The years are when the filings name Keith Flaherty in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Keith Flaherty works with at each company, as listed on that company's latest Form D.
Strata Oncology, Inc. · Form D, Nov 22, 2024
MM
Matthew Martin
Chief Financial Officer
DR
Daniel Rhodes
Executive officer and director
Christopher O'Donnell
Director
JW
Jeffrey Williams
Executive officer and director
DR
David Rubin
Director
JP
James Pavlik
Director
JG
Jan Garfinkle
Director